Phase None Recruiting NCT05857995

Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and Communities

Jerod L Stapleton, PhD · Interventional, Randomized · n=300

15 views

Rate this page

★ ★ ★ ★ ★

Lung Cancer

Study context Single-site study

Overview

The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. The project involves a two-group parallel randomized clinical trial comparing the impact of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) among lung cancer survivors (N=300) against an enhanced usual care condition (bibliotherapy+assessment) on quality of life outcomes.

Full record on ClinicalTrials.gov (NCT ID NCT05857995).

Eligibility

Age range: ≥ 18 · Sex: All · Healthy volunteers: Requires diagnosis

Study design

Phase: Phase None
Study type: Interventional
Allocation: Randomized
Masking: Double-blind
Intervention model: Parallel assignment
Primary purpose: Supportive Care
Enrollment target: 300 participants
Started: August 2024
Estimated completion: March 2028

Outcome measures

Locations & contactsⁱ

Showing 1 of 1 sites

1 site currently enrolling. Representative sites shown below; full site list on ClinicalTrials.gov.

Markey Cancer Center — Lexington, Kentucky (United States)

Sources

REG

ClinicalTrials.gov — NCT05857995

Trial registry · primary record